Aspiriant LLC’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-502
| Closed | -$218K | – | 311 |
|
|
2025
Q1 | $218K | Buy |
+502
| New | +$218K | 0.01% | 279 |
|
|
2024
Q4 | – | Sell |
-492
| Closed | -$256K | – | 295 |
|
|
2024
Q3 | $256K | Sell |
492
-187
| -28% | -$97.2K | 0.01% | 251 |
|
|
2024
Q2 | $368K | Sell |
679
-370
| -35% | -$200K | 0.02% | 210 |
|
|
2024
Q1 | $544K | Buy |
1,049
+10
| +1% | +$5.19K | 0.02% | 191 |
|
|
2023
Q4 | $490K | Sell |
1,039
-60
| -5% | -$28.3K | 0.02% | 191 |
|
|
2023
Q3 | $479K | Buy |
1,099
+240
| +28% | +$105K | 0.02% | 183 |
|
|
2023
Q2 | $382K | Sell |
859
-197
| -19% | -$87.5K | 0.02% | 198 |
|
|
2023
Q1 | $486K | Buy |
1,056
+194
| +23% | +$89.2K | 0.03% | 178 |
|
|
2022
Q4 | $442K | Buy |
862
+276
| +47% | +$142K | 0.02% | 185 |
|
|
2022
Q3 | $265K | Buy |
586
+104
| +22% | +$47K | 0.01% | 219 |
|
|
2022
Q2 | $233K | Sell |
482
-12
| -2% | -$5.8K | 0.01% | 244 |
|
|
2022
Q1 | $243K | Buy |
+494
| New | +$243K | 0.01% | 249 |
|